Media
Here in the media centre you will find a range of resources including our latest and archived press releases, information on our social media policy, and our photo and video library.
Press releases
GSK receives FDA approval for expanded indication for FluLaval® Quadrivalent (Influenza Vaccine) for infants 6 months and older
GSK announces new data from phase III studies of sirukumab in adult patients with moderately to severely active rheumatoid arthritis
These press releases are intended for business journalists & analysts/investors.